122 related articles for article (PubMed ID: 9274788)
1. Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma.
Theodoropoulos GE; Panoussopoulos D; Lazaris AC; Golematis BC
J Surg Oncol; 1997 Aug; 65(4):242-8. PubMed ID: 9274788
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases.
Têtu B; Brisson J; Lapointe H; Wang CS; Bernard P; Blanchette C
Breast Cancer Res Treat; 1999 May; 55(2):137-47. PubMed ID: 10481941
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
4. Influence of cathepsin D expression in lung adenocarcinoma on prognosis: possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S
J Surg Oncol; 1997 May; 65(1):10-9. PubMed ID: 9179261
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B in the growth of colorectal cancer: increased activity of cathepsin B in human colorectal cancer.
Satoh Y; Higashi T; Nouso K; Shiota T; Kinugasa N; Yoshida K; Uematsu S; Nakatsukasa H; Nishimura Y; Tsuji T
Acta Med Okayama; 1996 Dec; 50(6):305-11. PubMed ID: 8985467
[TBL] [Abstract][Full Text] [Related]
6. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
7. Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients.
Wyss J; Dislich B; Koelzer VH; Galván JA; Dawson H; Hädrich M; Inderbitzin D; Lugli A; Zlobec I; Berger MD
Clin Colorectal Cancer; 2019 Mar; 18(1):e20-e38. PubMed ID: 30389315
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma.
González-Vela MC; Garijo MF; Fernández F; Buelta L; Val-Bernal JF
Histopathology; 1999 Jan; 34(1):35-42. PubMed ID: 9934582
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
10. Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.
Secco GB; Fardelli R; Campora E; Lapertosa G; Gentile R; Zoli S; Prior C
Oncology; 1994; 51(1):30-4. PubMed ID: 8265100
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
13. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters.
Adenis A; Huet G; Zerimech F; Hecquet B; Balduyck M; Peyrat JP
Cancer Lett; 1995 Sep; 96(2):267-75. PubMed ID: 7585467
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal exoglycosidases and cathepsin D in colon adenocarcinoma.
Waszkiewicz N; Zalewska-Szajda B; Szajda SD; Kępka A; Waszkiewicz M; Roszkowska-Jakimiec W; Wojewódzka-Żeleźniakowicz M; Milewska AJ; Dadan J; Szulc A; Zwierz K; Ladny JR
Pol Arch Med Wewn; 2012; 122(11):551-6. PubMed ID: 23111620
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 1999 Aug; 31(3):247-51. PubMed ID: 10503271
[TBL] [Abstract][Full Text] [Related]
17. Expression of pyrimidine nucleoside phosphorylase (PyNPase) in colorectal cancer.
Osanai T; Ichikawa W; Takagi Y; Uetake H; Nihei Z; Sugihara K
Jpn J Clin Oncol; 2001 Oct; 31(10):500-5. PubMed ID: 11696620
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of cathepsin D in colorectal tumors.
Arao J; Fukui H; Ono Y; Ueda Y; Chiba T; Fujimori T
Dis Colon Rectum; 2000 Mar; 43(3):396-401. PubMed ID: 10733123
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]